Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic exclusivity. Eslicarbazepine acetate tablets are the generic of Sumitomo Pharma America’s Aptiom.

Gov. Gavin Newsom has made California the first state to offer a generic version of the overdose-reversal drug Narcan for public purchase through a state-run storefront, while the state’s health ...

Kowloon Generic Romance episode 4 is scheduled to be released on Saturday, April 26, 2025, at 11 PM JST. Episode 3 further developed the mystery and simulation aspect that has been present in the ...

A generic version of Wegovy is not yet available in the United States. Certain patents for Wegovy will expire in several years’ time. Once that occurs, a generic version may become available in ...

Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...

The Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 Billion by 2030. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.10% ...

Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms ...

AstraZeneca has launched new lawsuits against four generic drug manufacturers in an ongoing patent battle over its cancer drug Lynparza (olaparib), approved to treat ovarian, pancreatic ...

AI communities of practice can help us face its challenges head on Over the past year, I have redesigned the guiding questions in the General Chemistry II laboratory manual with “generic prompts”.

In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.

Oct 16 (Reuters) - Novartis (NOVN.S), opens new tab has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from ...